Roy T. Eddleman serves as Executive at REPLIGEN CORP, where they oversee executive responsibilities. Since joining the company, Roy T. Eddleman has executed 18 insider transactions totaling $23.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 29, 2021 involved receiving (via award) 421,052 shares valued at $2.0M.
Roy T. Eddleman currently holds 1,232,888 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roy T. Eddleman has been a net seller of RGEN stock. They have purchased $0 and sold $23.2M worth of shares.
Roy T. Eddleman's most recent insider trade was on Apr 29, 2021, when they sold 421,052 shares at $4.75 per share.
Get notified when new Form 4 filings are submitted
| $49.54 |
| Discretionary |
| Aug 9, 2018 | RGEN | $3.8M | Sale | 76,858 | $49.67 | Discretionary |
| Aug 8, 2018 | RGEN | $234.0K | Sale | 4,770 | $49.05 | Discretionary |
| Aug 7, 2018 | RGEN | $785.5K | Sale | 16,015 | $49.05 | Discretionary |
| Aug 6, 2018 | RGEN | $1.6M | Sale | 33,142 | $49.05 | Discretionary |
| Jun 13, 2018 | RGEN | $0 | Gift | 22,530 | $N/A | Discretionary |
| May 16, 2018 | RGEN | $5.0M | Sale | 118,850 | $42.07 | Discretionary |
| May 9, 2018 | RGEN | $1.0M | Sale | 25,000 | $40.37 | Discretionary |
| May 9, 2018 | RGEN | $841.7K | Sale | 20,773 | $40.52 | Discretionary |
| May 9, 2018 | RGEN | $1.0M | Sale | 25,000 | $40.37 | Discretionary |
| May 9, 2018 | RGEN | $841.7K | Sale | 20,773 | $40.52 | Discretionary |
| May 8, 2018 | RGEN | $1.0M | Sale | 25,000 | $40.66 | Discretionary |
| May 8, 2018 | RGEN | $2.0M | Sale | 49,227 | $40.77 | Discretionary |
| May 8, 2018 | RGEN | $2.0M | Sale | 49,227 | $40.77 | Discretionary |
| May 8, 2018 | RGEN | $1.0M | Sale | 25,000 | $40.66 | Discretionary |
| Dec 27, 2017 | RGEN | $0 | Gift | 900,000 | $N/A | Discretionary |
| Dec 27, 2017 | RGEN | $0 | Gift | 480,000 | $N/A | Discretionary |